ziconotide acetate

ziconotide acetate (PRIALT) is an FDA-listed pharmaceutical active ingredient. Route of administration: intrathecal. Current US regulatory status: approved.

PRIALT is a marketed brand name for ziconotide acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

ziconotide acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.